Close
Nordic 9Nordic 9

LongRiver Investments (investor - Venture Capital)

China
See something wrong or missing? Let us know
Offices:Hong Kong

LongRiver Investments is a venture capital firm founded in China in 2022 and headquartered in Hong Kong

Average round investment:N/A USD
Average number per year:0.0
Distribution: 2025 (1)
Portfolio companies: United Kingdom CamGene
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to LongRiver Investments

Name Criteria
Canada Hex two
80%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Active last 12 months: Yes
Sweden Triathlon Group
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Sweden Ekeblad Bostad
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Italy Golgi NueroSciences
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Japan Oji Holdings Corporation
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
China Fuho Capital
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
United Kingdom The Oxford Foundry
76%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
Finland DevCo Partners
73%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Sweden Mertiva
73%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Germany JIH family office
73%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Top